Lanzamiento Enero 2027

Ensayo controlado aleatorizado2022Acceso abierto

The FADS1 rs174550 Genotype Modifies the n-3 and n-6 PUFA and Lipid Mediator Responses to a High Alpha-Linolenic Acid and High Linoleic Acid Diets

Meuronen T, Lankinen MA, Kolmert J, de Mello VD, Sallinen T, Ågren J, Virtanen KA, Laakso M, Wheelock CE, Pihlajamäki J, Schwab U

Molecular nutrition & food research · 7 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación independiente
Universidad u hospital
Itä-Suomen Yliopisto
Gobierno
Academy of Finland
Organización sin fines de lucro
Suomen Kulttuurirahasto
Organización sin fines de lucro
Hjärt-Lungfonden
Organización sin fines de lucro
Pohjois-Savon Rahasto
Subvenciones
Hjärt-Lungfonden (20200693); Academy of Finland (321428); Hjärt-Lungfonden (#20210519); Academy of Finland (309311); Hjärt-Lungfonden (HLF 20210519)

Según 5 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2022-11-11 · Mol Nutr Food Res · vol. 66 · número 24 · pág. e2200351
Editorial
Wiley
Citado
9 citas · más que el 73% de estudios similares · 1.0× el promedio de su campo
Referencias
49 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY
Áreas de investigación
Fatty Acid Research and Health · Nutrition, Genetics, and Disease · Lipid metabolism and biosynthesis
Palabras clave
fatty acid desaturase, alpha-linolenic acid, linoleic acid, dietary polyunsaturated fatty acids, plasma lipid profile, arachidonic acid, eicosapentaenoic acid, cyclooxygenase metabolites, gene-diet interaction
MeSH
humans, fatty acid desaturases, alpha-linolenic acid, fatty acids, fatty acids, unsaturated, linoleic acid, diet, genotype, polymorphism, single nucleotide

11 autores

  • Topi Meuronen🇫🇮 · autor de correspondenciaUniversity of Turku; University of Eastern Finland
  • Maria Anneli Lankinen🇫🇮University of Eastern Finland
  • Johan Kolmert🇸🇪Karolinska Institutet
  • Vanessa D. de Mello🇫🇮University of Eastern Finland
  • Taisa Sallinen🇫🇮University of Eastern Finland
  • Jyrki Ågren🇫🇮University of Eastern Finland
  • Kirsi A. Virtanen🇫🇮University of Eastern Finland; Kuopio University Hospital
  • Markku Laakso🇫🇮University of Eastern Finland; Kuopio University Hospital
  • Craig E. Wheelock🇸🇪🇯🇵Karolinska University Hospital; Gunma University; Karolinska Institutet
  • Jussi Pihlajamäki🇫🇮University of Eastern Finland; Kuopio University Hospital
  • Ursula Schwab🇫🇮University of Eastern Finland; Kuopio University Hospital

Resumen

El texto original del estudio, en el idioma en que se publicó.

Scope

The fatty acid composition of plasma lipids, which is associated with biomarkers and risk of non-communicable diseases, is regulated by dietary polyunsaturated fatty acids (PUFAs) and variants of fatty acid desaturase (FADS). We investigated the interactions between dietary PUFAs and FADS1 rs174550 variant.

Methods and results

Participants (n = 118), homozygous for FADS1 rs174550 variant (TT and CC) followed a high alpha-linolenic acid (ALA, 5 percent of energy (E-%)) or a high linoleic acid (LA, 10 E-%) diet during an 8-week randomized controlled intervention. Fatty acid composition of plasma lipids and PUFA-derived lipid mediators were quantified by gas and liquid chromatography mass spectrometry, respectively. The high-LA diet increased the concentration of plasma LA, but not its lipid mediators. The concentration of plasma arachidonic acid decreased in carriers of CC and remained unchanged in the TT genotype. The high-ALA diet increased the concentration of plasma ALA and its cytochrome P450-derived epoxides and dihydroxys, and cyclooxygenase-derived monohydroxys. Concentrations of plasma eicosapentaenoic acid and its mono- and dihydroxys increased only in TT genotype carriers.

Conclusions

These findings suggest the potential for genotype-based recommendations for PUFA consumption, resulting in modulation of bioactive lipid mediators which can exert beneficial effects in maintaining health.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.